CAR-T-cell Treatment for Untreated High Risk MANtle Cell Lymphoma
Clinical trial NCT06482684 · RECRUITING
Trial details
- NCT number
- NCT06482684
- Sponsor
- Christian Schmidt, MD
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-15
- Primary completion
- 2031-06-15
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.